UnitedHealth acquires DaVita Medical Group for $4.9bn

By Catherine Sturman
Following on from the merger of CVS Health and Aetna, DaVita Medical Group’s clinics have been acquired by UnitedHealth for $4.9bn. Subject to regulat...

Following on from the merger of CVS Health and Aetna, DaVita Medical Group’s clinics have been acquired by UnitedHealth for $4.9bn. Subject to regulatory approval, the deal will see DaVita become part of United’s Optum unit, encompassing its outpatient operations, covering homecare, consulting, clinics and its pharmaceutical operations. 

The merger of CVS Health and Aetna highlights how the US healthcare industry is continuing to transform in the face of political uncertainties, alongside the utilisation of new technologies to drive down increasing healthcare costs and provide increased value to patients.

Through the acquisition, DaVita’s 2,000 strong team will merge with UnitedHealth’s 30,000 strong workforce, who will work to support DaVita’s 300 clinics and over 1.5mn patients across six US states.

Related stories

With a $5mn operating loss in its third quarter, DaVita aims to further undergo “significant stock repurchases,” within its operations following the close of the deal, all of which will further improve its future in the healthcare industry.

“This acquisition fits right into UNH’s [UnitedHealth Group’s] plan to direct patients from high-cost hospital settings to lower-cost urgent care and outpatient facilities and will leverage its vast physician footprint to accelerate that change,” commented Raymond James analyst Michael J.

One company sure to benefit from the acquisition is Berkshire Hathaway, which holds a 20% stake in the company. The deal has seen Berkshire gain over $231mn, and has seen DaVita shares rise significantly upon the announcement.

Share

Featured Articles

Philips Future Health Index Report: AI to Cut Waiting Times

Healthcare technology leader Philips says virtual care and AI is turning in an effort to cope with demand in its Future Health Index Report 2024

HCLTech and Olympus Advance AI into the Healthcare Industry

Giants HCLTech and Olympus Corporation, have developed their partnership to utilise technology and AI to transform the healthcare industry.

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Health Insurance & Finance

McKinsey: National E-health Initiatives on the Rise

Technology & AI

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma